share

6,7-Dihydro[1,2,4]Triazolo[5,1-B]Quinazolin-8(5H)-One CAS NO 777867-04-6


Unit Price:

CAS No.:777867-04-6

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

6,7-Dihydro[1,2,4]Triazolo[5,1-B]Quinazolin-8(5H)-One is a high-value, fused heterocyclic compound that serves as a critical synthetic intermediate and pharmacophore in advanced research and development. Its unique triazoloquinazolinone scaffold makes it a versatile building block for creating novel molecules with targeted biological activity. This compound is primarily sought after by pharmaceutical R&D teams, agrochemical innovators, and academic research institutions engaged in medicinal chemistry and drug discovery programs.

Application

  • Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates targeting various therapeutic areas, including central nervous system (CNS) disorders, oncology, and inflammation.
  • Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies and library synthesis to explore new chemical space for biological activity.
  • Agrochemical Development: Serves as a building block for creating new active ingredients with potential herbicidal, fungicidal, or insecticidal properties.
  • Biochemical Tool Compound: Utilized in biochemical assays and as a probe to study specific enzyme interactions or biological pathways in academic and industrial labs.
  • Organic Synthesis Building Block: Employed in advanced organic synthesis for constructing complex, polycyclic molecular architectures due to its reactive functional groups.

Basic Information

Product Name 6,7-Dihydro[1,2,4]Triazolo[5,1-B]Quinazolin-8(5H)-One
CAS No. 777867-04-6
Molecular Formula C10H8N4O
Molecular Weight 200.20 g/mol
Synonyms 5H-[1,2,4]Triazolo[5,1-b]quinazolin-8-one, 6,7-dihydro-; 6,7-Dihydro-5H-[1,2,4]triazolo[5,1-b]quinazolin-8-one; 777867-04-6; Triazoloquinazolinone derivative; [1,2,4]Triazolo[5,1-b]quinazolin-8(5H)-one, 6,7-dihydro-; 8H-[1,2,4]Triazolo[5,1-b]quinazolin-8-one, 6,7-dihydro-
EINECS Contact for details

Quality Control

Our production of 6,7-Dihydro[1,2,4]Triazolo[5,1-B]Quinazolin-8(5H)-One adheres to stringent quality management protocols to ensure batch-to-batch consistency and high purity for research applications. All materials are characterized using advanced analytical techniques including HPLC, NMR, and mass spectrometry. A comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles is provided with every shipment to support your quality assurance and regulatory documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to protect the compound from moisture.

Specification

Item Specification
Appearance White to off-white powder
Identification (IR) Conforms to structure
Identification (HPLC) Retention time matches reference standard
Purity (HPLC) ≥ 97.0%
Water Content (KF) ≤ 0.5%
Residue on Ignition ≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.